- Home
- / Recombinetics
Recombinetics
Total Funding
$61 M
Recombinetics Summary
Company Summary
- Overview
- Recombinetics is a biotechnology company offering gene repair and gene-editing solutions. It specializes in the application of precision genetic technologies and active patent filings in animals.
- Type
- Private
- Status
- Active
- Founded
- 2008
- HQ
- Eagan, MN, US | view all locations
- Website
- http://recombinetics.com
- Cybersecurity rating
Table of Contents
Key People
Mark Platt, Chief Executive Officer
David Aberle, Chief Financial Officer & VP of Finance
Tad Sonstegard, Chief Executive and Scientific Officer of Acceligen
LocationsView all
1 location detected
Eagan, MN HQ
United States
3388 Mike Collins Dr